The role of circulating fibrocytes in inflammation and autoimmunity

Journal of Leukocyte Biology

Volumn 93, Issue 1, 2013, Pages 45-50

  Galligan, Carole L ^a   Fish, Eleanor N ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Chemokines; Cytokines; Graves' disease; Rheumatoid arthritis; Scleroderma

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4;

AUTOIMMUNITY; BONE MARROW CELL; CELL COUNT; CELL FUNCTION; CELL GROWTH; CELL LINEAGE; CELL TRANSPORT; DISEASE ASSOCIATION; FIBROCYTE; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS;

AUTOIMMUNITY; BONE MARROW CELLS; HUMANS; INFLAMMATION;

EID: 84871945372     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0712365     Document Type: Review

References (100)

1. Richard-Miceli, C., Criswell, L. A. (2012) Emerging patterns of genetic overlap across autoimmune disorders. Genome Med. 4, 6.
2. Invernizzi, P., Gershwin, M. E. (2009) The genetics of human autoimmune disease. J. Autoimmun. 33, 290-299.
3. Panayi, G. S. (1997) T-cell-dependent pathways in rheumatoid arthritis. Curr. Opin. Rheumatol. 9, 236-240.
4. Takemura, S., Klimiuk, P. A., Braun, A., Goronzy, J. J., Weyand, C. M. (2001) T cell activation in rheumatoid synovium is B cell dependent. J. Immunol. 167, 4710-4718.
5. Mewar, D., Wilson, A. G. (2006) Autoantibodies in rheumatoid arthritis: a review. Biomed. Pharmacother. 60, 648-655.
6. Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., Cerami, A. (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1, 71-81.
7. Galligan, C. L., Fish, E. N. (2012) Circulating fibrocytes contribute to the pathogenesis of arthritis. Arthritis Rheum. doi 10.1002/art. 34589 [Epub ahead of print].
8. Reilkoff, R. A., Bucala, R., Herzog, E. L. (2011) Fibrocytes: emerging effector cells in chronic inflammation. Nat. Rev. Immunol. 11, 427-435.
9. Strieter, R. M., Keeley, E. C., Hughes, M. A., Burdick, M. D., Mehrad, B. (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J. Leukoc. Biol. 86, 1111-1118.
10. Dunphy, J. (1963) The fibroblast-a unique ally for the surgeon. N. Engl. J. Med. 268, 1367-1377.
11. Mori, L., Bellini, A., Stacey, M. A., Schmidt, M., Mattoli, S. (2005) Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp. Cell. Res. 304, 81-90.
12. Roderfeld, M., Rath, T., Voswinckel, R., Dierkes, C., Dietrich, H., Zahner, D., Graf, J., Roeb, E. (2010) Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice. Hepatology 51, 267-276.
13. Curnow, S. J., Fairclough, M., Schmutz, C., Kissane, S., Denniston, A. K., Nash, K., Buckley, C. D., Lord, J. M., Salmon, M. (2010) Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum. PLoS One 5, e9730.
14. Niedermeier, M., Reich, B., Rodriguez Gomez, M., Denzel, A., Schmidbauer, K., Gobel, N., Talke, Y., Schweda, F., Mack, M. (2009) CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc. Natl. Acad. Sci. USA 106, 17892-17897.
15. Ogawa, M., LaRue, A. C., Drake, C. J. (2006) Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications. Blood 108, 2893-2896.
16. Choi, Y. H., Burdick, M. D., Strieter, R. M. (2010) Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes. Int. J. Biochem. Cell Biol. 42, 662-671.
17. Hong, K. M., Burdick, M. D., Phillips, R. J., Heber, D., Strieter, R. M. (2005) Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice. FASEB J. 19, 2029-2031.
18. Quan, T. E., Cowper, S., Wu, S. P., Bockenstedt, L. K., Bucala, R. (2004) Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int. J. Biochem. Cell Biol. 36, 598-606.
19. He, Q., Wan, C., Li, G. (2007) Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 25, 69-77.
20. Kisseleva, T., von Kockritz-Blickwede, M., Reichart, D., McGillvray, S. M., Wingender, G., Kronenberg, M., Glass, C. K., Nizet, V., Brenner, D. A. (2011) Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection. J. Mol. Med. (Berl). 89, 997-1013.
21. Abe, R., Donnelly, S. C., Peng, T., Bucala, R., Metz, C. N. (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166, 7556-7562.
22. Chesney, J., Metz, C., Stavitsky, A. B., Bacher, M., Bucala, R. (1998) Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J. Immunol. 160, 419-425.
23. Pilling, D., Fan, T., Huang, D., Kaul, B., Gomer, R. H. (2009) Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 4, e7475.
24. Gomperts, B. N., Strieter, R. M. (2007) Fibrocytes in lung disease. J. Leukoc. Biol. 82, 449-456.
25. Galligan, C. L., Siminovitch, K. A., Keystone, E. C., Bykerk, V., Perez, O. D., Fish, E. N. (2010) Fibrocyte activation in rheumatoid arthritis. Rheumatology (Oxford) 49, 640-651.
26. Strieter, R. M., Keeley, E. C., Burdick, M. D., Mehrad, B. (2009) The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis. Trans. Am. Clin. Climatol. Assoc. 120, 49-59.
27. Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., Strieter, R. M. (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114, 438-446.
28. Kisseleva, T., Uchinami, H., Feirt, N., Quintana-Bustamante, O., Segovia, J. C., Schwabe, R. F., Brenner, D. A. (2006) Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 45, 429-438.
29. Lin, S. L., Kisseleva, T., Brenner, D. A., Duffield, J. S. (2008) Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617-1627.
30. Schmidt, M., Sun, G., Stacey, M. A., Mori, L., Mattoli, S. (2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171, 380-389.
31. Bucala, R. (2008) Circulating fibrocytes: cellular basis for NSF. J. Am. Coll. Radiol. 5, 36-39.
32. Vakil, V., Sung, J. J., Piecychna, M., Crawford, J. R., Kuo, P., Abu-Alfa, A. K., Cowper, S. E., Bucala, R., Gomer, R. H. (2009) Gadolinium-containing magnetic resonance image contrast agent promotes fibrocyte differentiation. J. Magn. Reson. Imaging 30, 1284-1288.
33. Field, J. J., Burdick, M. D., DeBaun, M. R., Strieter, B. A., Liu, L., Mehrad, B., Rose C. E., Jr., Linden, J., Strieter, R. M. (2012) The role of fibrocytes in sickle cell lung disease. Plos One 7, e33702.
34. Mathai, S. K., Gulati, M., Peng, X., Russell, T. R., Shaw, A. C., Rubinowitz, A. N., Murray, L. A., Siner, J. M., Antin-Ozerkis, D. E., Montgomery, R. R., Reilkoff, R. A., Bucala, R. J., Herzog, E. L. (2010) Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab. Invest. 90, 812-823.
35. Gan, Y., Reilkoff, R., Peng, X., Russell, T., Chen, Q., Mathai, S. K., Homer, R., Gulati, M., Siner, J., Elias, J., Bucala, R., Herzog, E. (2011) Role of semaphorin 7a signaling in transforming growth factor _1-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum. 63, 2484-2494.
36. Peng, X., Mathai, S. K., Murray, L. A., Russell, T., Reilkoff, R., Chen, Q., Gulati, M., Elias, J. A., Bucala, R., Gan, Y., Herzog, E. L. (2011) Local apoptosis promotes collagen production by monocyte-derived cells in transforming growth factor β 1-induced lung fibrosis. Fibrogenesis Tissue Repair 4, 12.
37. Douglas, R. S., Afifiyan, N. F., Hwang, C. J., Chong, K., Haider, U., Richards, P., Gianoukakis, A. G., Smith, T. J. (2010) Increased generation of fibrocytes in thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 95, 430-438.
38. Moore, B. B., Murray, L., Das, A., Wilke, C. A., Herrygers, A. B., Toews, G. B. (2006) The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am. J. Respir. Cell Mol. Biol. 35, 175-181.
39. Sakai, N., Wada, T., Yokoyama, H., Lipp, M., Ueha, S., Matsushima, K., Kaneko, S. (2006) Secondary lymphoid tissue chemokine (SLC/ CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc. Natl. Acad. Sci. USA 103, 14098-14103.
40. Sakai, N., Wada, T., Matsushima, K., Bucala, R., Iwai, M., Horiuchi, M., Kaneko, S. (2008) The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes. J. Hypertens. 26, 780-790.
41. Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., Wilke, C. A., Toews, G. B. (2005) CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am. J. Pathol. 166, 675-684.
42. Van Deventer, H. W., Wu, Q. P., Bergstralh, D. T., Davis, B. K., O'Connor, B. P., Ting, J. P., Serody, J. S. (2008) C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. Am. J. Pathol. 173, 253-264.
43. Kim, K. W., Cho, M. L., Kim, H. R., Ju, J. H., Park, M. K., Oh, H. J., Kim, J. S., Park, S. H., Lee, S. H., Kim, H. Y. (2007) Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin- 17 and CD40L-CD40 interaction. Arthritis Rheum. 56, 1076-1086.
44. Yang, M. H., Wu, F. X., Xie, C. M., Qing, Y. F., Wang, G. R., Guo, X. L., Tang, Z., Zhou, J. G., Yuan, G. H. (2009) Expression of CC chemokine ligand 5 in patients with rheumatoid arthritis and its correlation with disease activity and medication. Chin. Med. Sci. J. 24, 50-54.
45. Page, G., Miossec, P. (2004) Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. J. Pathol. 204, 28-38.
46. Kokkonen, H., Soderstrom, I., Rocklov, J., Hallmans, G., Lejon, K., Rantapaa Dahlqvist, S. (2010) Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum. 62, 383-391.
47. Koch, A. E., Kunkel, S. L., Harlow, L. A., Johnson, B., Evanoff, H. L., Haines, G. K., Burdick, M. D., Pope, R. M., Strieter, R. M. (1992) Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 90, 772-779.
48. Iwamoto, T., Okamoto, H., Toyama, Y., Momohara, S. (2008) Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J. 275, 4448-4455.
49. Boiardi, L., Macchioni, P., Meliconi, R., Pulsatelli, L., Facchini, A., Salvarani, C. (1999) Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate. Clin. Exp. Rheumatol. 17, 419-425.
50. Hwang, C. J., Afifiyan, N., Sand, D., Naik, V., Said, J., Pollock, S. J., Chen, B., Phipps, R. P., Goldberg, R. A., Smith, T. J., Douglas, R. S. (2009) Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest. Ophthalmol. Vis. Sci. 50, 2262-2268.
51. Postlethwaite, A. E., Shigemitsu, H., Kanangat, S. (2004) Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr. Opin. Rheumatol. 16, 733-738.
52. Codullo, V., Baldwin, H. M., Singh, M. D., Fraser, A. R., Wilson, C., Gilmour, A., Hueber, A. J., Bonino, C., McInnes, I. B., Montecucco, C., Graham, G. J. (2011) An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. Ann. Rheum. Dis. 70, 1115-1121.
53. Gambichler, T., Skrygan, M., Labanski, A. A., Kolios, A. G., Altmeyer, P., Kreuter, A. (2011) Significantly increased CCL5/RANTES and CCR7 mRNA levels in localized scleroderma. Regul. Pept. 170, 4-6.
54. Kaneko, H., Ogasawara, H., Naito, T., Akimoto, H., Lee, S., Hishikawa, T., Sekigawa, I., Tokano, Y., Takasaki, Y., Hirose, S. I., Hashimoto, H. (1999) Circulating levels of _-chemokines in systemic lupus erythematosus. J. Rheumatol. 26, 568-573.
55. Lit, L. C., Wong, C. K., Tam, L. S., Li, E. K., Lam, C. W. (2006) Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 65, 209-215.
56. Wallace, V. A., Kondo, S., Kono, T., Xing, Z., Timms, E., Furlonger, C., Keystone, E., Gauldie, J., Sauder, D. N., Mak, T. W. (1994) A role for CD4+T cells in the pathogenesis of skin fibrosis in tight skin mice. Eur. J. Immunol. 24, 1463-1466.
57. Saito, E., Fujimoto, M., Hasegawa, M., Komura, K., Hamaguchi, Y., Kaburagi, Y., Nagaoka, T., Takehara, K., Tedder, T. F., Sato, S. (2002) CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J. Clin. Invest. 109, 1453-1462.
58. Siracusa, L. D., McGrath, R., Fisher, J. K., Jimenez, S. A. (1998) The mouse tight skin (Tsk) phenotype is not dependent on the presence of mature T and B lymphocytes. Mamm. Genome 9, 907-909.
59. Dodig, T. D., Mack, K. T., Cassarino, D. F., Clark, S. H. (2001) Development of the tight-skin phenotype in immune-deficient mice. Arthritis Rheum. 44, 723-727.
60. Shao, D. D., Suresh, R., Vakil, V., Gomer, R. H., Pilling, D. (2008) Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J. Leukoc. Biol. 83, 1323-1333.
61. Raza, K., Falciani, F., Curnow, S. J., Ross, E. J., Lee, C. Y., Akbar, A. N., Lord, J. M., Gordon, C., Buckley, C. D., Salmon, M. (2005) Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res. Ther. 7, R784-R795.
62. Moriyama, M., Hayashida, J. N., Toyoshima, T., Ohyama, Y., Shinozaki, S., Tanaka, A., Maehara, T., Nakamura, S. (2012) Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren's syndrome. Clin. Exp. Immunol. 169, 17-26.
63. Sakkas, L. I., Chikanza, I. C., Platsoucas, C. D. (2006) Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nat. Clin. Pract. Rheumatol. 2, 679-685.
64. Higashi-Kuwata, N., Makino, T., Inoue, Y., Takeya, M., Ihn, H. (2009) Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma. Exp. Dermatol. 18, 727-729.
65. Kopf, M., Le Gros, G., Bachmann, M., Lamers, M. C., Bluethmann, H., Kohler, G. (1993) Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245-248.
66. Crawford, J. R., Pilling, D., Gomer, R. H. (2012) Fc_RI mediates serum amyloid P inhibition of fibrocyte differentiation. J. Leukoc. Biol. 92 [Epub ahead of print].
67. Inforzato, A., Bottazzi, B., Garlanda, C., Valentino, S., Mantovani, A. (2012) Pentraxins in humoral innate immunity. Adv. Exp. Med. Biol. 946, 1-20.
68. Nauta, A. J., Daha, M. R., van Kooten, C., Roos, A. (2003) Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol. 24, 148-154.
69. Zandman-Goddard, G., Blank, M., Langevitz, P., Slutsky, L., Pras, M., Levy, Y., Shovman, O., Witte, T., Doria, A., Rovensky, J., Shoenfeld, Y. (2005) Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann. Rheum. Dis. 64, 1698-1702.
70. Pilling, D., Buckley, C. D., Salmon, M., Gomer, R. H. (2003) Inhibition of fibrocyte differentiation by serum amyloid P. J. Immunol. 171, 5537-5546.
71. Koca, S. S., Isik, A., Ozercan, I. H., Ustundag, B., Evren, B., Metin, K. (2008) Effectiveness of etanercept in bleomycin-induced experimental scleroderma. Rheumatology (Oxford) 47, 172-175.
72. Piguet, P. F., Vesin, C. (1994) Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur. Respir. J. 7, 515-518.
73. Kitaori, T., Ito, H., Schwarz, E. M., Tsutsumi, R., Yoshitomi, H., Oishi, S., Nakano, M., Fujii, N., Nagasawa, T., Nakamura, T. (2009) Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis. Rheum. 60, 813-823.
74. Maharjan, A. S., Pilling, D., Gomer, R. H. (2010) Toll-like receptor 2 agonists inhibit human fibrocyte differentiation. Fibrogenesis Tissue Repair 3, 23.
75. Wang, J., Jiao, H., Stewart, T. L., Shankowsky, H. A., Scott, P. G., Tredget, E. E. (2007) Improvement in postburn hypertrophic scar after treatment with IFN-α2b is associated with decreased fibrocytes. J. Interferon Cytokine Res. 27, 921-930.
76. Forster, S. (2012) Interferon signatures in immune disorders and disease. Immunol. Cell Biol. 90, 520-527.
77. Leask, A., Abraham, D. J. (2004) TGF-β signaling and the fibrotic response. FASEB J. 18, 816-827.
78. Murray, L. A., Chen, Q., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Peng, X., Gulati, M., Homer, R. J., Russell, T., van Rooijen, N., Elias, J. A., Hogaboam, C. M., Herzog, E. L. (2010) TGF-β driven lung fibrosis is macrophage dependent and blocked by serum amyloid P. Int. J. Biochem. Cell Biol. 43, 154-162.
79. Kang, H. R., Lee, C. G., Homer, R. J., Elias, J. A. (2007) Semaphorin 7A plays a critical role in TGF-β1-induced pulmonary fibrosis. J. Exp. Med. 204, 1083-1093.
80. Eickholt, B. J. (2008) Functional diversity and mechanisms of action of the semaphorins. Development 135, 2689-2694.
81. Mantel, P. Y., Schmidt-Weber, C. B. (2010) Transforming growth factor-β: recent advances on its role in immune tolerance. Methods Mol. Biol. 677, 303-338.
82. Gillespie, E. F., Papageorgiou, K. I., Fernando, R., Raychaudhuri, N., Cockerham, K. P., Charara, L. K., Goncalves, A. C., Zhao, S. X., Ginter, A., Lu, Y., Smith, T. J., Douglas, R. S. (2012) Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production. J. Clin. Endocrinol. Metab. 97, E740-E746.
83. Garcia-de-Alba, C., Becerril, C., Ruiz, V., Gonzalez, Y., Reyes, S., Garcia- Alvarez, J., Selman, M., Pardo, A. (2010) Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. Am. J. Respir. Crit. Care Med. 182, 1144-1152.
84. Hartlapp, I., Abe, R., Saeed, R. W., Peng, T., Voelter, W., Bucala, R., Metz, C. N. (2001) Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J. 15, 2215-2224.
85. Reines, B. P. (2004) Is rheumatoid arthritis premature osteoarthritis with fetal-like healing? Autoimmun. Rev. 3, 305-311.
86. Chesney, J., Bacher, M., Bender, A., Bucala, R. (1997) The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc. Natl. Acad. Sci. USA 94, 6307-6312.
87. Yu, Q., Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase- 9 proteolytically activates TGF-αand promotes tumor invasion and angiogenesis. Genes Dev. 14, 163-176.
88. Riddell, M. R., Winkler-Lowen, B., Chakrabarti, S., Dunk, C., Davidge, S. T., Guilbert, L. J. (2012) The characterization of fibrocyte-like cells: a novel fibroblastic cell of the placenta. Placenta 33, 143-150.
89. Mulherin, D., Fitzgerald, O., Bresnihan, B. (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 39, 115-124.
90. Wright, H. L., Moots, R. J., Bucknall, R. C., Edwards, S. W. (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 49, 1618-1631.
91. Nemeth, T., Mocsai, A. (2012) The role of neutrophils in autoimmune diseases. Immunol. Lett. 143, 9-19.
92. Knight, J.S., Kaplan, M. J. (2012) Lupus neutrophils: 'NET' gain in understanding lupus pathogenesis. Curr. Opin. Rheumatol. 24, 441-450.
93. Turesson, C., O'Fallon, W. M., Crowson, C. S., Gabriel, S. E., Matteson, E. L. (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J. Rheumatol. 29, 62-67.
94. Gabriel, S. E., Crowson, C. S., Kremers, H. M., Doran, M. F., Turesson, C., O'Fallon, W. M., Matteson, E. L. (2003) Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 48, 54-58.
95. Chu, P. Y., Mariani, J., Finch, S., McMullen, J. R., Sadoshima, J., Marshall, T., Kaye, D. M. (2010) Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am. J. Pathol. 176, 1735-1742.
96. Wolfe, F., Mitchell, D. M., Sibley, J. T., Fries, J. F., Bloch, D. A., Williams, C. A., Spitz, P. W., Haga, M., Kleinheksel, S. M., Cathey, M. A. (1994) The mortality of rheumatoid arthritis. Arthritis Rheum. 37, 481-494.
97. Medbury, H. J., Tarran, S. L., Guiffre, A. K., Williams, M. M., Lam, T. H., Vicaretti, M., Fletcher, J. P. (2008) Monocytes contribute to the atherosclerotic cap by transformation into fibrocytes. Int. Angiol. 27, 114-123.
98. Fang, L., Moore, X. L., Chan, W., White, D. A., Chin-Dusting, J., Dart, A. M. (2012) Decreased fibrocyte number is associated with atherosclerotic plaque instability in man. Cardiovasc. Res. 95, 124-133.
99. Andersson-Sjoland, A., de Alba, C. G., Nihlberg, K., Becerril, C., Ramirez, R., Pardo, A., Westergren-Thorsson, G., Selman, M. (2008) Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int. J. Biochem. Cell Biol. 40, 2129-2140.
100. Nagy, N., Biro, E., Takacs, A., Polos, M., Magyar, A., Olah, I. (2005) Peripheral blood fibrocytes contribute to the formation of the avian spleen. Dev. Dyn. 232, 55-66.